AU2003250958A1 - Use of cd152 for treating autoimmune diseases and inflammations - Google Patents

Use of cd152 for treating autoimmune diseases and inflammations

Info

Publication number: AU2003250958A1
Authority: AU; Australia
Prior art keywords: inflammations; autoimmune diseases; treating autoimmune; treating; diseases
Prior art date: 2002-07-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003250958A

Other versions

AU2003250958A8 (en

Inventor

Monika Brunner-Weinzierl

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Charite Universitaetsmedizin Berlin

Original Assignee

Charite Universitaetsmedizin Berlin

Universitatsklinikum Charite Berlin

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-15

Filing date

2003-07-15

Publication date

2004-02-02

2003-07-15 Application filed by Charite Universitaetsmedizin Berlin, Universitatsklinikum Charite Berlin filed Critical Charite Universitaetsmedizin Berlin

2004-02-02 Publication of AU2003250958A8 publication Critical patent/AU2003250958A8/en

2004-02-02 Publication of AU2003250958A1 publication Critical patent/AU2003250958A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Cell Biology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AU2003250958A 2002-07-15 2003-07-15 Use of cd152 for treating autoimmune diseases and inflammations Abandoned AU2003250958A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10232697A DE10232697A1 (en)	2002-07-15	2002-07-15	Use of CD152 for the treatment of autoimmune diseases and inflammation
DE10232697.5		2002-07-15
PCT/EP2003/007665 WO2004006950A2 (en)	2002-07-15	2003-07-15	Use of cd152 for treating autoimmune diseases and inflammations

Publications (2)

Publication Number	Publication Date
AU2003250958A8 AU2003250958A8 (en)	2004-02-02
AU2003250958A1 true AU2003250958A1 (en)	2004-02-02

Family

ID=30010180

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003250958A Abandoned AU2003250958A1 (en)	2002-07-15	2003-07-15	Use of cd152 for treating autoimmune diseases and inflammations

Country Status (3)

Country	Link
AU (1)	AU2003250958A1 (en)
DE (2)	DE10232697A1 (en)
WO (1)	WO2004006950A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8475790B2 (en)	2008-10-06	2013-07-02	Bristol-Myers Squibb Company	Combination of CD137 antibody and CTLA-4 antibody for the treatment of proliferative diseases
EP2961416B1 (en)	2013-03-01	2019-11-13	The United States of America, as represented by The Secretary, Department of Health and Human Services	Methods of producing enriched populations of tumor reactive t cells from peripheral blood

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4723782B2 (en) *	2000-01-03	2011-07-13	ティーアールアソシエイツ，エル．エル．シー．	Novel chimeric protein and method of using the protein
EP3029062A1 (en) *	2000-05-26	2016-06-08	Bristol-Myers Squibb Company	Soluble ctla4 mutant molecules and uses thereof
DE10038722C2 (en) *	2000-08-09	2002-07-25	Genethor Gmbh	Procedure for the reduction of specific immune reactions

2002
- 2002-07-15 DE DE10232697A patent/DE10232697A1/en not_active Withdrawn
2003
- 2003-07-15 DE DE10392933T patent/DE10392933B4/en not_active Expired - Fee Related
- 2003-07-15 WO PCT/EP2003/007665 patent/WO2004006950A2/en not_active Ceased
- 2003-07-15 AU AU2003250958A patent/AU2003250958A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2003250958A8 (en)	2004-02-02
DE10392933B4 (en)	2007-04-12
WO2004006950A3 (en)	2004-06-10
WO2004006950A2 (en)	2004-01-22
DE10392933D2 (en)	2005-07-14
DE10232697A1 (en)	2004-02-05

Similar Documents

Publication	Publication Date	Title
AU2003290548A1 (en)	2004-06-07	Prevention and treatment of synucleinopathic disease
WO2003072035A8 (en)	2005-07-28	Compositions and methods for the treatment of immune related diseases
WO2004041170A9 (en)	2010-01-21	Compositions and methods for the treatment of immune related diseases
AU2003239568A1 (en)	2003-12-12	Pyrrolotriazinone compounds and their use to treat diseases
WO2004024097A9 (en)	2010-01-21	Compositions and methods for the treatment of immune related diseases
AU2003231048A1 (en)	2003-11-03	Transposon system and methods of use
AU2003268531A1 (en)	2004-03-29	Materials and methods for treatment of allergic diseases
AU2003236211A1 (en)	2003-10-27	Smac-peptides as therapeutics against cancer and autoimmune diseases
AU2003225281A1 (en)	2003-11-17	Materials and methods for prevention and treatment of rna viral diseases
AU2003298911A1 (en)	2004-06-23	Cyclosporins for the treatment of autoimmune diseases
AU2003267532A1 (en)	2004-02-09	PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES
AU2003268295A1 (en)	2004-03-19	"diagnosis and treatment of infertility"
AU2003295343A1 (en)	2004-04-23	Uses of human zven proteins and polynucleotides
AU2003260778A1 (en)	2004-03-29	Treatment of pipes
AU2003206945A1 (en)	2003-09-09	Use of proteinase inhibitors in the treatment of autoimmune diseases
AU2003274963A1 (en)	2004-07-29	Mda-7 and free radicals in the treatment of cancer
AU2003259833A1 (en)	2004-03-03	Methods of treating neurodegenerative diseases
AU2003222250A1 (en)	2004-01-23	Treatment of autoimmune diseases
AU1537601A (en)	2001-06-04	Treatment of autoimmune diseases by an agonistic CD40-binding protein
AU2003256447A1 (en)	2004-01-23	Treatment of autoimmune skin diseases
AU2003287802A1 (en)	2004-06-15	Palpometer and methods of use thereof
AU2003213898A1 (en)	2003-10-13	Prevention and treatment of mycoplasma-associated diseases
AU2003250958A1 (en)	2004-02-02	Use of cd152 for treating autoimmune diseases and inflammations
AU2003270815A1 (en)	2004-04-08	Treatment of irritable bowel syndrome and related bowel diseases
AU2003302271A1 (en)	2004-07-29	Methods of treating and/or preventing autoimmune diseases

Legal Events

Date	Code	Title	Description
2005-04-14	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase